Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Chugai Pharmaceutical Co., Ltd. announced that the company filed a new drug application (NDA) for R744, a long–acting erythropoiesis–stimulating agent, for the treatment of anemia associated with chronic kidney disease with the Japanese Ministry of Health, Labour and Welfare.

Today in Regulatory Issues...keeping you current

Two Delivery Systems Win Baldrige Award
HealthDataManagement, 12/17/09

Advisory Committee briefing materials for CRESTOR sNDA available on US FDA web site
AstraZeneca, 12/15/09

Sixteen Fired for Records Snooping
HealthDataManagement, 12/09/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address